Chinese mobile content platform Qutoutiao (lit. fun headlines) reported revenue of 1.41 billion yuan, up 26.2% from the previous year in its Q1 2020 earnings report released on Thursday.
As SAIC-GM-Wuling Joint Venture introduces a new van to support small businesses, both of its shares and sales increased.
While media reported that Megvii suspended its IPO listing in HK, Megvii told us it's false.
After receiving $70 million cross-border investment in 2018, Chinese RTC service provider Agora.io these days planned its U.S. IPO.
On May 7, Budweiser Asia Pacific announced its unaudited Q1 2020 financial results. The company’s revenue in Q1 fell by 39%, while its revenue in the Chinese market fell by as much as 45.4%.
Having faked its revenue numbers, Luckin became a laughing stock of a unicorn, with analysts on both sides of the pond contemplating over what outcomes this situation will have on a larger scale for Chinese businesses abroad.
Global financial markets are struggling, having been crippled by the COVID-19 epidemic and the amount of VC deals has noticeably decreased.
The past week saw exciting news surface regarding several players in China’s AI and automation space, with one of the most prominent AI unicorns 4Padadigm raising two hefty rounds and adding another $1 billion to its valuation.
Chinese e-commerce giant Alibaba Group's Taobao launched its consumer-to-manufacturer (C2M) system to bring 10 billion orders across China over the next three years.
The coronavirus outbreak is still in full force, limiting business opportunities and impelling investors to put their activities on hold.
DecodeChina is an exclusive opportunity for globally-minded, tech-obsessed professionals to dive into China’s tech scene through company visits, courses and workshops, networking events, and much more!
The Chinese commercial drone developer EHang Holdings announced its terms for the US IPO on December 5.
On November 24, a former NetEase employee suffering from a terminal illness spoke up on social media, accusing the gaming giant of unfair treatment.
I-Mab, a Shanghai-based developer of biologic treatments for cancers and autoimmune disorders, has filed for an IPO on the Nasdaq under the symbol “IMAB”.
Two decades after the premiere of the original Mulan, Disney released the first teaser-trailer for its live-action reproduction of the iconic cartoon.